Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 CAD | -1.34% | +2.08% | -17.88% |
Apr. 11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
Apr. 11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Bearish |
Resistance | 1.590 | 1.700 | 2.350 |
Spread/Res. | -7.55% | -13.53% | -37.45% |
Spread/Supp. | +9.70% | +21.49% | +9.70% |
Support | 1.340 | 1.210 | 1.340 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ONC Stock
- Charts Oncolytics Biotech Inc.